Standout Papers
Citation Impact
Citing Papers
Clinical guidelines on the management of hepatitis C
2001
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
2001 StandoutScienceNobel
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Chemokine and Chemokine Receptor Interactions Provide a Mechanism for Selective T Cell Recruitment to Specific Liver Compartments Within Hepatitis C-Infected Liver
1999
Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow.
1974
Liver biopsy in chronic hepatitis: 1968-78.
1978
Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.
1982
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29-year longitudinal study
2006
$beta;-Adrenergic function in heart muscle disease and heart failure
1985
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Protection against persistence of hepatitis C
2002
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial
2007
Hepatitis C Virus–Specific CD4+T Cell Response after Liver Transplantation Occurs Early, Is Multispecific, Compartmentalizes to the Liver, and Does Not Correlate with Recurrent Disease
2001 StandoutNobel
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
2012
Peginterferon alfa‐2a for hepatitis C after liver transplantation
2005
Intra-observer variation in the histopathological assessment of chronic viral hepatitis
1996
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
2007
A Pilot Study of Therapeutic Vaccination With Envelope Protein E1 in 35 Patients With Chronic Hepatitis C
2003
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Hepatitis C Virus Infection
2001 Standout
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
2003 Standout
Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats
2002
Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitor
1998
A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B
2000
The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B
2001
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Ribavirin and Interferon Is Effective for Hepatitis C Virus Clearance in Hepatitis B and C Dually Infected Patients
2003
Long–Term Suppression of Hepatitis B E Antigen–Negative Chronic Hepatitis B by 24–Month Interferon Therapy
2003
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Nonalcoholic Fatty Liver Disease
2002 Standout
Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: A pilot randomized controlled study
1998
Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection
2002
Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery before the Implementation of Blood-Donor Screening
1999
Hepatitis C virus replication in ‘autoimmune’ chronic hepatitis
1991 StandoutNobel
Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons
2004
Preferential loss of IL‐2–secreting CD4+ T helper cells in chronic HCV infection†
2005
Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders
2000
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
NONALCOHOLIC STEATOHEPATITIS
1996
Peginterferon and Ribavirin Treatment in African American and Caucasian American Patients With Hepatitis C Genotype 1
2006
CM-101: Type I Collagen–targeted MR Imaging Probe for Detection of Liver Fibrosis
2017
Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis
1990
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study
2005
Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver Disease
2008
Liver biopsy†
2008
Interferon Therapy for Chronic Hepatitis C in Hemodialysis Patients: Increased Serum Levels of Interferon
1998
Sustained virological response rates and health‐related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels
2006
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Long‐term follow‐up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver‐related complications
2006
Ursodeoxycholic Acid or Clofibrate in the Treatment of Non–Alcohol–Induced Steatohepatitis: A Pilot Study
1996
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
2005
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Characterization of Liver T–Cell Receptor γδ+ T Cells Obtained From Individuals Chronically Infected With Hepatitis C Virus (Hcv): Evidence for These T Cells Playing A Role in the Liver Pathology Associated With Hcv Infections
2001 StandoutNobel
Long term effect of alpha interferon in children with chronic hepatitis B
2000
Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels
1997
Liver-Derived Hepatitis C Virus (HCV)-Specific CD4+ T Cells Recognize Multiple HCV Epitopes and Produce Interferon Gamma
2000 StandoutNobel
Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease
2003
Liver/Kidney Microsome Antibody Type 1 and Hepatitis C Virus Infection
1992
Pegylated Interferon‐α‐2a plus Ribavirin for Treatment‐Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial
2008
Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
2005
Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
1998
Three-dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications
2004
Glial and neuronal control of brain blood flow
2010 StandoutNature
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment
2001
Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response
2007
Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: A 20-year multicenter study
2000
Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C
2002
Chronic hepatitis B
2007 Standout
Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA
2001
Interferon α Treatment and Retreatment of Hepatitis B e Antigen-Negative Chronic Hepatitis B
2001
Role of Liver Biopsy in the Evaluation of Hepatitis C Virus Infection in HIV Coinfection
2005
Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study
2005
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
2008
Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels
2004
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients
2004
Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection
1999
Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin
2006
Fibrosis and disease progression in hepatitis C
2002
Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores
1998
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
1999 Standout
Classification of chronic viral hepatitis: a need for reassessment
1991
The nomenclature of chronic active hepatitis: An obituary
1993
Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts.
1994 StandoutNobel
Application of a numerical scoring system for assessment of histological outcome in patients with chronic posttransfusion non‐A, non‐B hepatitis with or without antibodies to hepatitis C
1990
HCV‐related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferonα‐2a and ribavirin
2006
Myocardial Reperfusion Injury
2007 Standout
Outcome of Hepatitis B e Antigen–Negative Chronic Hepatitis B on Long-Term Nucleos(t)ide Analog Therapy Starting With Lamivudine *
2005
Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women
2000
Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease
2002
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection
2006
Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence
2007
Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy
2004
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Peginterferon Alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment[1], [2] and [3] 1 2 3☆
2004
Serum markers detect the presence of liver fibrosis: A cohort study
2004
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
2004
High Doses of alpha-Interferon Are Required in Chronic Hepatitis Due to Coinfection With Hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial
2001
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D
2006
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
2002 Standout
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance
2004
The role of liver biopsy in chronic hepatitis C
2002
De novo reconstitution of a functional mammalian urinary bladder by tissue engineering
1999
Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C Trial
2007
Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?
2000
Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C†
2005
Preemptive Therapy for Hepatitis C Virus after Living-Donor Liver Transplantation
2004
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Chronic hepatitis C in children: The pathological and clinical spectrum
1998
Hepatocellular Carcinoma
2011 Standout
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels
2000
Resolution of liver cirrhosis using vitamin A–coupled liposomes to deliver siRNA against a collagen-specific chaperone
2008
The Long–Term Pathological Evolution of Chronic Hepatitis C
1996
Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
2009
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
2008
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
1999
Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2004
Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin
2006
The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection
2005
Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation
1999 StandoutNobel
Outcomes of acute rejection after interferon therapy in liver transplant recipients
2004
Nonalcoholic Steatohepatitis
1980 Standout
Fibrosis and disease progression in hepatitis C
2002
Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C
1994 Standout
Hepatocellular Carcinoma
2019 Standout
End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage
2007
Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA index
2005
Clinical, Virologic and Histologic Outcome Following Seroconversion From Hbeag to Anti–Hbe in Chronic Hepatitis Type B
1986
Noninvasive markers of hepatic fibrosis: Are they ready for prime time in the management of HIV/HCV co-infected patients?
2005
Cytoskeleton Antibodies in Chronic Active Hepatitis, Primary Biliary Cirrhosis, and Alcoholic Liver Disease
1983
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic Receptor
1994 StandoutScienceNobel
Pathologic aspects of cirrhosis. A review.
1977
Clinical, Biochemical, and Histological Remission of Severe Chronic Active Liver Disease: A Controlled Study of Treatments and Early Prognosis
1972
Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following challenge
2003 StandoutNobel
Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog.
1983
Hydrogels for Tissue Engineering
2001 Standout
Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up
1997
Natural History of Hepatitis C
2005
Prevalence of Hepatitis C–Related Cirrhosis in Elderly Asian Patients Infected in Childhood
2005
Treatment of Dialysis Patients with Chronic Hepatitis C Using Pegylated Interferon and Low-Dose Ribavirin
2008
The role of liver biopsy in chronic hepatitis C
2002
Exploring and Engineering the Cell Surface Interface
2005 StandoutScience
Tissue-engineered autologous bladders for patients needing cystoplasty
2006 Standout
The Vocabulary of Chronic Hepatitis
1971
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C
2001
Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy
1971
Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels
1997
Transmission of Hepatitis C by Intrahepatic Inoculation with Transcribed RNA
1997 StandoutScienceNobel
Chronic active liver disease
1972
Cardiac Function in Mice Overexpressing the β-Adrenergic Receptor Kinase or a βARK Inhibitor
1995 StandoutScienceNobel
The pathology of viral hepatitis in chimpanzees
1980
The pathology of viral hepatitis in chimpanzees.
1980
Regulation of intracellular fluid volume and disease
1970
The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the Dog
1974 Standout
Improvement in Myocardial Function and Coronary Blood Flow in Ischemic Myocardium after Mannitol
1972
Cerebral ischemia. II. The no-reflow phenomenon.
1968
CHARACTERISATION OF A NEW SUBGROUP OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS BY AUTOANTIBODIES AGAINST A SOLUBLE LIVER ANTIGEN
1987
Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients
1995
THE VARIATION OF PATHOLOGICAL CHANGES IN THE LIVER EVALUATED BY DOUBLE BIOPSIES
1979
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†
1981 Standout
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests
2005
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.
1990 StandoutNobel
Chronic active hepatitis
1980
AASLD position paper: Liver biopsy
2008
Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C
2005
Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis
1981
Chronic Hepatitis C Virus Infection in Childhood: Clinical Patterns and Evolution in 224 White Children
2003
Classification of chronic hepatitis: Diagnosis, grading and staging
1994 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Works of G Korb being referenced
Alloplastic Replacement of the Urinary Bladder Wall with Lyophilized Human Dura
1970
Histological grading and staging of chronic hepatitis
1995 Standout
The diagnostic significance of periportal hepatic necrosis and inflammation
1988
Reduction of the Isoproterenol-Induced Alterations in Cardiac Adenine Nucleotides and Morphology by Ribose
1980 Science
Five-year follow-up study of patients with nonalcoholic and nondiabetic fatty liver.
1974
Systematik der chronischen Hepatitis
1968
A CLASSIFICATION OF CHRONIC HEPATITIS
1968
[Classification of chronic hepatitis].
1968
Hepatoprotection by malotilate against carbon tetrachloride-alcohol-induced liver fibrosis
1986
Blood Supply of the Myocardium after Temporary Coronary Occlusion
1966